Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MBAT-C for children with ADHD
NCT04737512Phase 1Completed
- Sponsor
- Yale University
- Start
- Feb 2021
- Primary completion
- Oct 2024
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial in attention deficit hyperactivity disorder (ADHD), sponsored by Yale University. Primary endpoints: Recruitment Rate at 30 months and Randomization Rate at 30 months. Started Feb 2021; status: completed.
02
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT04737512.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04737512.